prikaz prve stranice dokumenta Dugodjelujući antipsihotici u liječenju shizofrenije-stavovi psihijatara i pacijenata
  Download
PDF 1.04 MB
master's thesis
Dugodjelujući antipsihotici u liječenju shizofrenije-stavovi psihijatara i pacijenata
Zagreb: University of Zagreb, School of Medicine, 2016. urn:nbn:hr:105:416762
Bjedov, Sarah
University of Zagreb
School of Medicine
Department of Psychiatry and Psychological Medicine

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Bjedov, S. (2016). Dugodjelujući antipsihotici u liječenju shizofrenije-stavovi psihijatara i pacijenata (Master's thesis). Zagreb: University of Zagreb, School of Medicine. Retrieved from https://urn.nsk.hr/urn:nbn:hr:105:416762

Bjedov, Sarah. "Dugodjelujući antipsihotici u liječenju shizofrenije-stavovi psihijatara i pacijenata." Master's thesis, University of Zagreb, School of Medicine, 2016. https://urn.nsk.hr/urn:nbn:hr:105:416762

Bjedov, Sarah. "Dugodjelujući antipsihotici u liječenju shizofrenije-stavovi psihijatara i pacijenata." Master's thesis, University of Zagreb, School of Medicine, 2016. https://urn.nsk.hr/urn:nbn:hr:105:416762

Bjedov, S. (2016). 'Dugodjelujući antipsihotici u liječenju shizofrenije-stavovi psihijatara i pacijenata', Master's thesis, University of Zagreb, School of Medicine, accessed 10 November 2024, https://urn.nsk.hr/urn:nbn:hr:105:416762

Bjedov S. Dugodjelujući antipsihotici u liječenju shizofrenije-stavovi psihijatara i pacijenata [Master's thesis]. Zagreb: University of Zagreb, School of Medicine; 2016 [cited 2024 November 10] Available at: https://urn.nsk.hr/urn:nbn:hr:105:416762

S. Bjedov, "Dugodjelujući antipsihotici u liječenju shizofrenije-stavovi psihijatara i pacijenata", Master's thesis, University of Zagreb, School of Medicine, Zagreb, 2016. Available at: https://urn.nsk.hr/urn:nbn:hr:105:416762

Metadata
TitleDugodjelujući antipsihotici u liječenju shizofrenije-stavovi psihijatara i pacijenata
Title (english)Long-acting injectable antipsychotics in treatment of schizophrenia - attitudes of psychiatrists and patients
AuthorSarah Bjedov
MentorMiro Jakovljević (mentor)
Committee memberDarko Marčinko (predsjednik povjerenstva)
Committee memberDražen Begić (član povjerenstva)
Committee memberMiro Jakovljević (član povjerenstva)
GranterUniversity of Zagreb
School of Medicine
(Department of Psychiatry and Psychological Medicine)
Zagreb
Defense date and country2016-07-15, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Psychiatry
Abstract
Shizofrenija je kronična mentalna bolest koja se liječi oralnim i intramuskularnim antipsihoticima. Dugodjelujući intramuskularni antipsihotici (LAIA), unatoč potencijalno mnogim prednostima, rijetko se propisuju te je njihova primjena uglavnom rezervirana za nesuradljive bolesnike. Cilj ovog preliminarnog istraživanja bio je ispitati stavove psihijatara i pacijenata kako bismo dobili uvid u prednosti, nedostatke i moguće razloge rijetkog propisivanja LAIA. Sastavljene su tri ankete te je ispitano ukupno 48 psihijatara, 50 pacijenata liječenih oralnom terapijom i 50 pacijenata liječenih s LAIA. Usporedbom pacijenata, veći broj njih liječenih s LAIA osjeća poboljšanje (82%). 84% pacijenata liječenih s LAIA i 46% pacijenata liječenih oralnom terapijom smatra jednostavnijim način primjene lijeka jednom u dva do četiri tjedna. Iako 78% psihijatara navodi da je sklono propisivanju LAIA, mali je broj njihovih pacijenata kojima je to i propisano (medijan=20%). Unatoč pozitivnim stavovima pacijenata o LAIA, većina psihijatara (68,08%) smatra da pacijenti radije odabiru oralnu terapiju. Upravo bi zbog toga buduća istraživanja trebalo usmjeriti u detaljnije ispitivanje stavova i pacijenata i psihijatara o terapiji.
Abstract (english)
Schizophrenia is a chronic mental illness that can be treated with oral and intramuscular antipsychotics. Despite many potential benefits, long-acting injectable antipsychotics (LAIA) are rarely prescribed and their usage is mostly reserved for nonadherent patients. The aim of this preliminary research was to examinate attitudes of psychiatrists and patients to get a better insight into advantages, disadvantages and possible reasons for rarely prescribing of LAIA. Three different questionnaires were given to total of 48 psychiatrists, 50 patients treated with oral medication and 50 patients treated with LAIA. Comparison among patients shows that there is a larger number of patients treated with LAIA that feels better (82%). 84% of patients treated with LAIA and 46% of patients treated with oral medication consider the usage of LAIA more simple. Although 81,25% of psychiatrists state that they tend to prescribe LAIA, there is a small number of their patients that are using it (median=20%). Despite positive attitudes of patients toward LAIA, majority of psychiatrists (68,08%) think that patients would rather choose oral therapy. Precisely because of this, future researches should be focused on further examination of psychiatrists' and patients' attitudes toward therapy.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:105:416762
Study programmeTitle: Medicine
Study programme type: university
Study level: integrated undergraduate and graduate
Academic / professional title: doktor/doktorica medicine (doktor/doktorica medicine)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2017-08-22 09:52:37